# SIRT1 rs7069102 Polymorphism Confers Increased Risk of Diabetic Retinopathy in T2DM

**Authors:** Melina Bešić, Jernej Letonja, Mojca Globočnik Petrovič, Ana Peterlin, Ema Šuligoj, Stella Stare, Daniel Petrovič

PMC · DOI: 10.3390/genes17020221 · 2026-02-10

## TL;DR

This study found that a specific genetic variation in the SIRT1 gene increases the risk of diabetic retinopathy in people with type 2 diabetes.

## Contribution

The study identifies a novel association between the SIRT1 rs7069102 polymorphism and increased DR risk in T2DM patients.

## Key findings

- The SIRT1 rs7069102 polymorphism was significantly associated with diabetic retinopathy under a dominant model.
- Patients with CC or CG genotypes had a 30% higher risk of developing DR compared to those with the GG genotype.
- No significant link was found between the TNF-α rs1800629 polymorphism and DR.

## Abstract

Background: The incidence and prevalence of type 2 diabetes mellitus (T2DM) has been increasing worldwide recently. Diabetic retinopathy (DR) is a major ocular complication of diabetes mellitus, and it is the leading cause of blindness and visual impairment. Sirtuin 1 (SIRT 1) is a NAD+-dependent deacetylase and is involved in stress responses such as hypoxic and genotoxic stress, inflammation and heat shock. Tumor necrosis factor α (TNF-α) is an important inflammatory mediator that is involved in the pathogenesis of T2DM. The purpose of our study was to investigate the relationship between the SIRT1 rs7069102 polymorphism and TNF- α rs1800629 polymorphisms and diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM). Materials and Methods: We analyzed 1554 Slovenian (Caucasian) patients with T2DM of at least 10 years’ duration, stratifying them into two groups: 577 patients with diabetic retinopathy (DR) and 977 patients without DR. Genotyping of SIRT1 rs7069102 and TNF-α rs1800629 polymorphisms was performed using the StepOne real-time PCR System with TaqMan SNP Genotyping Assays. Results and Conclusions: A significant difference in the distribution of SIRT1 rs7069102 genotypes and alleles was observed between the groups. Under the dominant inheritance model, patients with CC or CG genotypes were more likely to develop DR than those with the GG genotype (OR = 1.30; 95% CI = 1.02–1.65; p = 0.036). No significant association was found between TNF-α rs1800629 and DR.

## Linked entities

- **Genes:** SIRT1 (sirtuin 1) [NCBI Gene 23411], TNF (tumor necrosis factor) [NCBI Gene 7124]
- **Diseases:** type 2 diabetes mellitus (MONDO:0005148), diabetic retinopathy (MONDO:0005266)

## Full-text entities

- **Genes:** MIR34A (microRNA 34a) [NCBI Gene 407040] {aka MIRN34A, miRNA34A, mir-34, mir-34a}, VCAM1 (vascular cell adhesion molecule 1) [NCBI Gene 7412] {aka CD106, INCAM-100}, SELP (selectin P) [NCBI Gene 6403] {aka CD62, CD62P, GMP140, GRMP, LECAM3, PADGEM}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, NVL (nuclear VCP like) [NCBI Gene 4931] {aka NVL2}, NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, SERPINE1 (serpin family E member 1) [NCBI Gene 5054] {aka PAI, PAI-1, PAI1, PLANH1}, Sirt3 (sirtuin 3) [NCBI Gene 64384] {aka 2310003L23Rik, Sir2l3}, AP2B1 (adaptor related protein complex 2 subunit beta 1) [NCBI Gene 163] {aka ADTB2, AP105B, AP2-BETA, CLAPB1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, MIR200B (microRNA 200b) [NCBI Gene 406984] {aka MIRN200B, mir-200b}, Sirt1 (sirtuin 1) [NCBI Gene 93759] {aka SIR2L1, Sir2, Sir2a, Sir2alpha}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, MTHFR (methylenetetrahydrofolate reductase) [NCBI Gene 4524]
- **Diseases:** DR (MESH:D003930), retinal inflammation (MESH:D012173), cardiovascular complications (MESH:D002318), macular oedema (MESH:D008269), diabetic neuropathy (MESH:D003929), PDR (MESH:C564461), insulin resistance (MESH:D007333), hyperinsulinemia (MESH:D006946), diabetic complications (MESH:D048909), hypertension (MESH:D006973), impaired glucose tolerance (MESH:D018149), diabetic nephropathy (MESH:D003928), visceral obesity (MESH:D056128), ocular diseases (MESH:D005128), neuropathy (MESH:D009422), nephropathy (MESH:D007674), T2DM (MESH:D003924), coronary artery disease (MESH:D003324), ischemic (MESH:D002545), Diabetic (MESH:D003920), Hyperglycemia (MESH:D006943), inflammation (MESH:D007249), injury to (MESH:D014947), pupil dilatation (MESH:D011681), visual impairment (MESH:D014786), blindness (MESH:D001766), obese (MESH:D009765), retinopathy (MESH:D058437)
- **Chemicals:** NAD+ (MESH:D009243), ROS (MESH:D017382), Glucose (MESH:D005947), lipid (MESH:D008055), phenylephrine (MESH:D010656), triglycerides (MESH:D014280), tropicamide (MESH:D014331), TGS (MESH:C026285), insulin (MESH:D007328), cholesterol (MESH:D002784)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** -308G>a, rs12778366, rs3758391, rs7896005, rs7069102

---
Source: https://tomesphere.com/paper/PMC12940320